News | Lung Imaging | October 05, 2015

Four-year post-treatment survival jumped 25 percent among patients who relapsed within 24 months

lung cancer survival rates, CT scan follow-up, computed tomography, improvement, ERS International Congress 2015

October 5, 2015 — Patients with recurrent lung cancer have better post-surgery survival rates if their management includes a follow-up program based on computer tomography (CT) of the chest, according to new findings.

The findings, presented at the European Respiratory Society (ERS) International Congress 2015 in Amsterdam, are the first to show improved overall survival after surgery for a CT-based follow-up program and could change the way patients are currently managed.

Previous research has confirmed that after the introduction of the CT-based follow-up, most cases of recurrent lung cancer can be detected before the patient has any symptoms. This allows for earlier diagnosis and leads to an improved chance of having a radical treatment against the relapse. This new study aimed to assess whether this follow-up also improved survival rates.

Researchers from the Odense University Hospital in Denmark assessed 391 patients who had surgery following a lung cancer diagnosis between 2008 and 2013. After the introduction of a CT- based follow-up in July 2010, all patients receives a scan every third month for two years and then every six months for three years. In May 2015, researchers recorded whether the patients were alive and free from lung cancer.

Results showed the number of patients alive four years after surgery increased from 54 percent to an estimated 68 percent. Additionally, for patients experiencing a relapse during the first 24 months after surgery, the chance of being alive four years after the first treatment increased from 2 percent to an estimated 27 percent.

Niels-Christian Hansen, M.D., presenting author on the study, commented: "Our results show a significant improvement for survival rates for patients post-surgery in a CT follow-up program currently running in Denmark. A key strength of our study is the real-life setting we used, where we were able to demonstrate successful results in a representative sample of lung cancer patients from Denmark. This is very encouraging news and we believe that our results could contribute to the planning of similar treatment programs in other centers and countries."

The authors plan to repeat the same kind of analysis for the group of lung cancer patients treated by radiation with the aim to cure, instead of by surgery, to see if the results are also successful for this group of patients.

The Danish Lung Cancer Group has funded a first preliminary report (in Danish) in November 2014. No other external funding has taken place.

For more information: www.erscongress.org


Related Content

News | Artificial Intelligence

Sept. 13, 2024 — Bayer Calantic Digital Solutions has announced the availability of a new eBook that addresses how ...

Time September 12, 2024
arrow
News | Computed Tomography (CT)

At the annual AHRA (American Healthcare Radiology Administrators) conference in Orlando, Florida, Bayer announced an ...

Time August 09, 2024
arrow
Videos | Radiology Business

Find actionable insights to achieve sustainability and savings in radiology in this newest of ITN’s “One on One” video ...

Time July 30, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 22, 2024 — Healthcare artificial intelligence (AI) systems provider, Qure.ai, has announced its receipt of a Class ...

Time July 22, 2024
arrow
News | PET-CT

July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...

Time July 16, 2024
arrow
News | Prostate Cancer

July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...

Time July 11, 2024
arrow
News | Radiation Therapy

July 3, 2024 — Results from a new study led by researchers at The University of Texas MD Anderson Cancer Center support ...

Time July 03, 2024
arrow
News | Artificial Intelligence

June 27, 2024 — Thirona, a Netherlands-based global company providing high-precision advanced lung image analysis with ...

Time June 27, 2024
arrow
Subscribe Now